They are commonly discussed in relation to:
- Fine skin texture
- Hydration
- Elasticity
- Fine lines
- Periocular skin quality
- Overall skin appearance
In some countries, related products are popularly referred to as “salmon DNA” treatments because purified nucleic-acid-derived materials used in certain formulations originate from salmonid sources.
However, the marketing term can create unnecessary confusion.
Polynucleotide treatment does not mean injecting genetic instructions into the face, and it does not alter the patient's DNA.
The clinically relevant questions are:
What does the product contain? Is it PN or PDRN-based? What is the indication? What tissue effect are we trying to achieve?
What Are Polynucleotides?
Polynucleotides are polymers composed of nucleotide units.
Purified polynucleotide-based materials are used in selected medical and aesthetic applications, where interest centers on their interaction with tissue repair and extracellular-matrix-related biological processes.
In aesthetic medicine, they are primarily used within skin-quality treatment strategies.
They should not be confused with conventional volumizing dermal fillers.
What Is PDRN?
PDRN stands for polydeoxyribonucleotide.
It refers to DNA-derived fragments with biological properties that have been investigated in areas including tissue repair and wound healing.
PN and PDRN are closely related terms and are often grouped together in aesthetic marketing.
However:
PN and PDRN should not automatically be treated as identical substances.
Commercial formulations can differ substantially.
PN vs PDRN
The distinction matters because patients frequently encounter all of the following terms online:
- PN
- PDRN
- Polynucleotide
- Salmon DNA
- DNA injection
These names can make different products appear identical.
Broadly:
PN refers to polynucleotide polymers.
PDRN refers to polydeoxyribonucleotide fragments with particular molecular characteristics.
The exact:
- Molecular profile
- Concentration
- Formulation
- Manufacturing process
- Approved or intended use
depends on the individual product.
For treatment planning, the product itself matters more than the marketing category.
What Is “Salmon DNA Treatment”?
“Salmon DNA” is a popular non-technical term used for certain PN/PDRN-related products produced from highly purified nucleic-acid-derived material.
It does not mean that salmon genetic information becomes incorporated into the patient's cells.
It also does not mean that the patient's DNA is modified.
A more accurate way to discuss these treatments is by identifying the specific PN or PDRN formulation being used.
Does Salmon DNA Change Human DNA?
No.
Polynucleotide or PDRN treatment is not gene therapy.
It does not:
- Rewrite DNA
- Change inherited characteristics
- Insert salmon genes into human cells
- Genetically rejuvenate the face
The word “DNA” describes the origin and molecular nature of the material—not genetic modification of the patient.
How Do Polynucleotides Work?
The proposed biological effects of PN/PDRN-related products are more complex than simple volume replacement.
Research has explored interactions involving:
- Tissue-repair pathways
- Extracellular matrix
- Fibroblast-related activity
- Inflammatory responses
- Tissue hydration
- Angiogenesis-related processes
depending on the specific material and experimental context.
However, this should not be simplified into:
“Polynucleotides create new skin.”
Clinical effects are more modest and biologically nuanced.
Are Polynucleotides Collagen Stimulators?
This requires careful wording.
Polynucleotide-related treatments have been investigated for effects involving fibroblasts and extracellular-matrix remodeling.
However, they should not automatically be equated with injectable products whose principal mechanism and clinical purpose is biostimulation with progressive volumetric collagen-related change.
It is more accurate to consider PN treatments primarily within the broader skin-quality and tissue-remodeling category.
What Can Polynucleotide Treatment Improve?
Depending on the patient and product, treatment may be considered for selected concerns involving:
- Fine skin texture
- Hydration
- Skin elasticity
- Fine superficial lines
- Crepey appearance
- Periocular skin quality
- Facial skin quality
- Neck skin quality
The expected improvement should remain proportional to the problem being treated.
Polynucleotides do not correct every sign of facial aging.
Polynucleotides for the Under-Eye Area
The periocular region is one of the most commonly discussed areas for PN treatment.
This is partly because patients may have thin, fine or crepey skin without necessarily needing substantial volume.
Selected patients may therefore be considered for treatment targeting:
- Fine texture
- Crepey skin
- Fine lines
- General periocular skin quality
But the diagnosis matters enormously.
Not Every Dark Circle Is a Skin-Quality Problem
“Dark circles” can be produced by several mechanisms:
- Epidermal or dermal pigmentation
- Visible vascular structures
- Thin skin
- Tear-trough depression
- Orbital anatomy
- Fat prolapse
- Shadowing
- Malar edema
A PN injection cannot correct all of these.
For example:
shadow caused by a tear trough is not the same problem as thin crepey skin.
Polynucleotides and Under-Eye Bags
Polynucleotides do not remove prolapsed orbital fat.
If the primary problem is a true lower-eyelid bag, the relevant anatomical issue may require assessment for lower blepharoplasty rather than repeated skin injections.
Similarly, significant lower-eyelid skin excess cannot simply be injected away.
Polynucleotides and Periorbital Edema
Patients prone to:
- Malar edema
- Festoons
- Persistent lower-eyelid swelling
require particular care with injectable treatments around the eyes.
The presence of a popular periocular product does not automatically mean the patient is an appropriate candidate for injection.
Polynucleotides for the Face
PN treatments can also be considered for selected facial skin-quality concerns.
Potential areas include:
- Cheeks
- Perioral region
- Lower face
- Selected forehead areas
depending on the product and indication.
The goal is generally not to reshape the face.
Polynucleotides for the Neck
The neck is another area where patients frequently seek improvement in:
- Fine texture
- Crepey skin
- Fine lines
- General skin quality
PN treatment may be incorporated into selected plans.
However, significant:
- Skin laxity
- Platysmal bands
- Submental fat
- Deep-neck fullness
cannot be corrected with polynucleotides.
Polynucleotides vs Skin Boosters
These categories overlap in the patient goal of improving skin quality but are not identical.
Skin Boosters
Frequently rely on hyaluronic-acid-based formulations to improve characteristics such as hydration and skin quality.
Polynucleotides
Use nucleotide-based materials and are discussed more in relation to tissue-quality and remodeling pathways.
Neither is universally better.
The decision depends on what aspect of skin quality is being targeted.
Polynucleotides vs Hyaluronic Acid Filler
The distinction is more substantial.
A structural HA filler may be used to create:
- Projection
- Volume
- Contour
- Structural support
PN treatments generally do not have this primary purpose.
Therefore, a patient with significant:
- Malar volume deficiency
- Chin retrusion
- Jawline deficiency
should not expect PN injections to reproduce the effect of appropriately placed structural filler.
Polynucleotides vs Jalupro
Jalupro products use different formulations, including amino-acid and hyaluronic-acid-related components depending on the specific product.
Polynucleotides use nucleotide-based material.
Both may be discussed within skin-quality medicine, but their compositions and biological rationale differ.
Polynucleotides vs NCTF
NCTF-type formulations are multi-component injectable products containing combinations of skin-quality-related ingredients.
PN products have a different molecular basis.
Therefore:
NCTF, Jalupro, PN and skin boosters should not all be presented as interchangeable “youth vaccines.”
Polynucleotides vs PRP
PRP is prepared from the patient's own blood.
PN products are manufactured nucleotide-based injectable materials.
So:
PRP = autologous blood-derived treatment
PN = manufactured polynucleotide-based treatment
Their biological composition and treatment rationale differ.
Polynucleotides vs Exosomes
They are completely different concepts.
Polynucleotides are nucleotide polymers.
Exosomes are extracellular vesicles involved in cell-to-cell signaling.
Neither should be called stem cells.
Are Polynucleotides Stem-Cell Therapy?
No.
Polynucleotide injections do not involve transplantation of stem cells.
Terms such as:
- Stem-cell facial
- Stem-cell injection
- Cellular rejuvenation
should not be used as synonyms for PN treatment.
Polynucleotides vs Botox
Botulinum toxin reduces selected neuromuscular activity.
PN treatments target skin-quality-related concerns.
Therefore:
Botulinum toxin → muscle activity
PN → skin quality
A forehead line caused predominantly by strong frontalis activity cannot be expected to respond to PN treatment in the same way as botulinum toxin.
Polynucleotides vs Microneedling
Microneedling creates controlled mechanical microinjury.
PN treatment introduces a nucleotide-based material into selected tissue planes.
They are different treatment mechanisms.
In selected cases they may form parts of a broader treatment strategy, but combination is not automatically necessary.
Polynucleotides vs Fractional CO₂ Laser
Fractional CO₂ produces controlled ablative and thermal remodeling.
It can have a much stronger effect on selected:
- Texture abnormalities
- Acne scars
- Surgical scars
- Photoaging
- Fine wrinkles
but also has a very different recovery profile.
PN treatment should not be marketed as an injectable equivalent of CO₂ resurfacing.
Can Polynucleotides Treat Acne Scars?
They should not be considered a primary structural treatment for significant atrophic acne scars.
Acne scars can be:
- Rolling
- Boxcar
- Ice-pick
and may require:
- Subcision
- Fractional resurfacing
- Microneedling
- Focal chemical treatment
- Volume restoration
depending on morphology.
A skin-quality injectable cannot mechanically release a tethered scar.
Can Polynucleotides Lift the Face?
No meaningful injectable skin-quality treatment should be described as reproducing surgical lifting.
Polynucleotides cannot anatomically reposition:
- Descended cheek tissues
- Jowls
- Deep facial compartments
- Significant neck laxity
The treatment target is different.
Can Polynucleotides Improve Fine Lines?
Selected fine lines associated with skin quality may improve.
However, the cause of the line matters.
A line may be predominantly:
- Dynamic
- Dermal
- Structural
- Volume-related
- Photodamage-related
and these require different treatment approaches.
How Is Polynucleotide Treatment Performed?
After assessment, the selected product is administered into appropriate tissue planes using an injection technique suited to the:
- Product
- Anatomical region
- Skin thickness
- Treatment objective
Small temporary papules may be visible after some superficial injection techniques.
Technique should follow the specific formulation and anatomical area rather than a universal injection pattern.
What Happens After Treatment?
Temporary effects can include:
- Small injection-site elevations
- Redness
- Swelling
- Bruising
- Tenderness
particularly in thin-skinned areas.
These usually evolve as the injected material distributes and the immediate injection response settles.
When Will I See Results?
PN treatments should not be understood as immediate structural fillers.
Some early perceived improvement can reflect:
- Hydration
- Injection-related swelling
- Temporary tissue changes
while biological skin-quality changes, when they occur, develop over time.
Immediate post-injection appearance should therefore not be interpreted as the final result.
How Many Sessions Are Needed?
There is no single protocol appropriate for every PN/PDRN product or patient.
Treatment plans vary according to:
- Product
- Concentration
- Treatment area
- Skin condition
- Patient response
- Manufacturer-specific recommendations
A preset package should not replace clinical reassessment.
How Long Do Polynucleotide Results Last?
Duration varies.
PN treatments should not be described as permanent.
Skin continues to age, and treatment effects can evolve with:
- Individual biology
- Product characteristics
- Lifestyle
- Sun exposure
- Treatment area
Maintenance may be considered when appropriate.
Risks of Polynucleotide Treatment
Potential effects and complications include:
- Redness
- Swelling
- Bruising
- Tenderness
- Injection-site papules
- Infection
- Inflammatory reaction
- Persistent swelling
- Nodules or product-related reactions
depending on the product and injection technique.
Any injectable treatment also requires detailed knowledge of regional anatomy.
Non-surgical does not mean risk-free.
Product Selection Matters
The phrase “salmon DNA” does not establish product quality.
Products may differ in:
- Purification
- Concentration
- Molecular characteristics
- Manufacturing
- Sterility
- Regulatory status
- Clinical evidence
Treatment should therefore be based on the actual product rather than the popularity of a category name.
Dr. Fatih Ceran's Approach to Polynucleotide Treatment
The first question should not be:
“Which salmon DNA brand should we inject?”
It should be:
What is the anatomical problem?
Is it:
Thin skin?
Fine texture?
Dehydration?
Crepey periocular skin?
Pigmentation?
Tear-trough shadow?
Orbital fat prolapse?
Malar edema?
Dynamic wrinkles?
Volume deficiency?
Facial descent?
Once the problem is identified, the next question is whether PN treatment is actually the appropriate mechanism.
Would the patient benefit more from:
- Polynucleotides?
- A skin booster?
- Botulinum toxin?
- Filler?
- Microneedling?
- Fractional laser?
- Blepharoplasty?
- Brow surgery?
- Facial rejuvenation surgery?
- Or no procedure at all?
The sequence should be:
diagnosis → anatomical level → treatment objective → product selection → injection technique → reassessment.
The objective is not to inject PN because it is fashionable.
It is to use it when the patient's skin problem actually matches what the treatment can reasonably address.
Frequently Asked Questions About Polynucleotides
What are polynucleotides?
They are nucleotide-based polymers used in selected injectable skin-quality treatments.
Is polynucleotide treatment the same as salmon DNA?
“Salmon DNA” is a popular term for certain PN/PDRN-related products, but identifying the actual formulation is more accurate.
Does salmon DNA alter my DNA?
No. PN/PDRN treatment is not gene therapy and does not rewrite the patient's genetic code.
Are PN and PDRN the same?
They are related but should not automatically be treated as identical. Their molecular characteristics and commercial formulations can differ.
Are polynucleotides fillers?
Not in the conventional structural volumizing sense. Their principal use is generally related to skin quality.
Are polynucleotides good for under-eye skin?
They can be considered for selected fine-texture and crepey-skin concerns, but they do not correct every cause of dark circles or under-eye bags.
Can salmon DNA remove under-eye bags?
No. True orbital fat prolapse is an anatomical problem and may require a different treatment.
Are polynucleotides stem cells?
No.
Which is better: polynucleotides or skin boosters?
Neither is universally better. They have different formulations and treatment rationales.
Can polynucleotides replace Botox?
No. Botulinum toxin targets muscle activity; PN treatment primarily targets skin-quality concerns.
Can polynucleotides lift the face?
They cannot reproduce surgical repositioning of descended facial tissues.
How many PN sessions are needed?
There is no universal number. The product, treatment area and individual response should determine the plan.